Clinical Trials Browser

OTHER_GOV × Docetaxel × Sarcoma × Clear all

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Phase 2 Unknown

Recurrence, Sarcoma